Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: Relation to liver fibrosis and arthritis
- 31 July 1991
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 25 (1) , 50-53
- https://doi.org/10.1016/0190-9622(91)70173-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Role of Liver Biopsies in Psoriatic Patients Receiving Long-term Methotrexate TreatmentArchives of Dermatology, 1989
- Methotrexate in psoriasis: Revised guidelinesJournal of the American Academy of Dermatology, 1988
- The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritisRheumatology International, 1988
- Type III Collagen Aminopropeptide Levels in Serum of Patients With Progressive Systemic SclerodermaJournal of Investigative Dermatology, 1986
- Methotrexate maintenance therapy and liver damage in psoriasisClinical and Experimental Dermatology, 1985
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†Hepatology, 1984
- Effects of Methotrexate on the Liver in PsoriasisJournal of Investigative Dermatology, 1974
- Psoriasis-Liver-Methotrexate InteractionsArchives of Dermatology, 1973